Investor Relations Contact

Ted Jenkins, Vice President, Head of Investor Relations
Spero Therapeutics
617-798-4039
tjenkins@sperotherapeutics.com

Ashley Robinson
LifeSci Advisors
617-430-7577
arr@lifesciadvisors.com